abstract |
The present invention relates to oligonucleotide compositions and their therapeutic use to modify protein-protein interactions. Specifically, the present invention relates to the use of oligonucleotides rich in guanidine that disrupt disease-causing protein aggregates, such as Huntington's disease (HD) protein aggregates. |